Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection

BACKGROUND: We estimate effectiveness of 3 versus 2 vaccine doses against SARS-CoV-2 B.1.1.529 Omicron in a mostly infection-naiive but highly vaccinated Australian population. METHODS: Cohort study of adults aged 40+ years resident in Sydney followed from 1 January 2022 for SARS-CoV-2 infection and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bette, Gidding, Heather, Stepien, Sandrine, Cretikos, Michelle, Macartney, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489983/
https://www.ncbi.nlm.nih.gov/pubmed/36180375
http://dx.doi.org/10.1016/j.vaccine.2022.09.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489983/
https://www.ncbi.nlm.nih.gov/pubmed/36180375
http://dx.doi.org/10.1016/j.vaccine.2022.09.029

Ejemplares similares